Donald A. Morgan

Donald A. Morgan

Auto-generated profile, based on publicly available information

Donald A. Morgan

The Univ of Iowa, Iowa City, IA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2018 in bioRxiv
Verified
Preprint
Open access
PDF file
AGAdilson Guilherme
Adilson Guilherme
DPDavid J Pedersen
David J Pedersen
FHFelipe Henriques
Felipe Henriques
ABAlexander H. Bedard
Alexander H. Bedard
EHElizabeth Henchey
Elizabeth Henchey
MCMichael P. Czech
Michael P. Czech
White adipose tissue (WAT) secretes factors to communicate with other metabolic organs to maintain energy homeostasis. We previously reported that perturbation of adipocyte de novo lipogenesis (DNL) by deletion of fatty acid synthase (FASN) causes expansion of sympathetic neurons within white adipose tissue (WAT) and the appearance of “beige” adipocytes. Here we report evidence that white adipocyte DNL activity is also coupled to neuronal regulation and thermogenesis in brown adipose tissue (BAT). Induced deletion of FASN in all adipocytes in mature mice (iAdFASNKO) enhanced sympathetic innervation and neuronal activity as well as UCP1 expression in both WAT and BAT. In contrast, selective ablation of FASN in brown adipocytes of mice (iUCP1FASNKO) failed to modulate sympathetic innervation and the thermogenic program in BAT. Surprisingly, DNL in brown adipocytes was also dispensable in maintaining euthermia when UCP1FASNKO mice were cold-exposed. These results indicate that DNL in white adipocytes influences long distance signaling to BAT, which can modify BAT sympathetic innervation and expression of genes involved in thermogenesis.

1 April 2013 in Endocrine Abstracts
Verified
Journal Article
Closed access
MIMonica Imbernon
Monica Imbernon
DBDaniel Beiroa
Daniel Beiroa
MVMaria J Vazquez
Maria J Vazquez
DMDonald A Morgan
Donald A Morgan
CVChristelle Veyrat-Durebex
Christelle Veyrat-Durebex
RNRuben Nogueiras
Ruben Nogueiras
Introduction: Melanin-concentrating hormone (MCH) is an orexigenic neuropeptide which is located in the lateral hypothalamus and regulate the energy balance. MCH deficient mice are hypophagic, lean and do not develop hepatosteatosis when fed on high fat diet. The MCH increases food intake and adiposity, so we sought to investigate the role of the MCH on adipocyte and hepatic metabolism. Methods: MCH were chronically administered into the lateral ventricles of rats brain, using osmotic pumps that released the MCH for a week. To study whether the sympathetic nervous system mediates the actions of MCH on white adipose tissue, deficient mice for the three beta-adrenergic receptors were used (triple knockout mice). To determine whether the central effect of MCH on the liver was mediated through the parasympathetic nervous system (PSNS), the vagus nerve was dissected. Adenoviral particles overexpressing MCH receptors (MCH-R) were estereotaxically administered into arcuate and lateral hypothalmus (LHA, ARC). Tissues were analyzed to determine the expression of genes and proteins involved in lipid metabolism of liver and fat. Results: The activation of MCH receptors (MCH-R) promotes the liver fat storage through the parasympathetic nervous system (PSNS), whereas it increases lipid deposition in WAT via the suppression of sympathetic traffic. These metabolic actions are independent of parallel changes in food intake and energy expenditure. Genetic activation of MCH-R increases body weight gain and food intake, specifically in the LHA modulated hepatic lipid metabolism, whereas the specific activation of this receptor in the arcuate nucleus affected adipocyte metabolism. Conclusions: Central MCH system increases lipid storage via modulation of adipocyte and hepatic metabolism. Activation of MCH-R in the ARC control adipocyte lipid metabolism via a SNS-dependent mechanism, while the activation of MCH-R in the LHA influences hepatic lipid metabolism through the PSNS.

1 September 2018 in Hypertension
Verified
Journal Article
Closed access
DGDeng-Fu Guo
Deng-Fu Guo
BBBalyssa Bell
Balyssa Bell
DMDonald A Morgan
Donald A Morgan
Huxing CuiHuxing Cui
Huxing Cui
JSJulien A Sebag
Julien A Sebag
KRKamal Rahmouni
Kamal Rahmouni
The brain melanocortin-4 receptor (MC4R) plays an important in the control of food intake and energy expenditure by increasing thermogenic sympathetic nerve activity (SNA). In addition, brain MC4R-mediated activation of SNA subserving cardiovascular organs such as the kidneys increase blood pressure. The melanocortin receptor accessory protein 2 (MRAP2) regulates the activity of the MC4R and other G-protein coupled receptors, but its specific role in MC4R-containing neurons is not clear . We hypothesized that MRAP2 in MC4R neurons is essential for the regulation of SNA, energy homeostasis and blood pressure. We generated mice (MRAP2 MC4R ) that lack MRAP2 in MC4R neurons by crossing MRAP2 fl/fl mice with MC4R Cre mice and confirmed Cre recombinase activity in MC4R neurons using td-Tomato reporter mice. Interestingly, the MRAP2 MC4R mice displayed obesity as indicated by the increased (p<0.05) body weight (males: 40.1±2.2 vs 32.9±0.9g in littermate controls, females: 28.6±2.8 vs 24.2±1.3g in controls at 16 weeks of age) and fat mass, but not lean mass. Weights of fat pads and liver were also significantly elevated in the MRAP2 MC4R relative to littermate controls. Food intake was increased in the MRAP2 MC4R mice relative to littermate controls (males: 4.7±0.3 vs 3.9±0.3g and females: 3.5±0.2 vs 2.8±0.2g). Glucose and insulin tolerance tests revealed impaired glucose tolerance and insulin-induced glucose clearance in MRAP2 MC4R mice compared to littermate controls. Baseline brown adipose tissue (BAT) SNA tended to be lower in MRAP2 MC4R mice relative to controls. Moreover, intracerebroventricular (icv) injection of MTII (MC4R agonist, 1 μg) increased BAT SNA in control mice (107±31%) but not in MRAP2 MC4R mice (18±24%, p=0.02). On the other hand, icv the MTII (1 and 2 μg)-induced increase in renal SNA (p=0.2) and blood pressure (p=0.4) was not different in MRAP2 MC4R (100±32% and 15±8mmHg, respectively) relative to controls (74±24% and 12±6mmHg). These findings support a critical role for MRAP2 in uncoupling neuronal MC4R-mediated control of regional sympathetic traffic impacting energy metabolism versus blood pressure.

1 September 2018 in Hypertension
Verified
Journal Article
Closed access
USUday Singh
Uday Singh
BTBrandon A. Toth
Brandon A. Toth
KDKevin C. Davis
Kevin C. Davis
KSKenji Saito
Kenji Saito
DMDonald A. Morgan
Donald A. Morgan
Huxing CuiHuxing Cui
Huxing Cui
It is well established that the central melanocortin system is critical for autonomic functions and energy homeostasis mainly via signaling at melanocortin-4 receptor (MC4R). Importantly, while obesity is commonly associated with elevated sympathetic tone and blood pressure, severely obese humans and rodents due to genetic MC4R deficiency exhibit normal to low sympathetic tone and blood pressure, suggesting a significant role of MC4R pathway in mediating obesity-associated sympathoexcitation and hypertension. MC4R is widely expressed in the brain including hypothalamic paraventricular nucleus (PVN) which regulates feeding and sympathetic traffic. However, the neuroanatomical basis of PVN MC4R neurons for sympathetic regulation is unclear. The goal of current study is to map the PVN MC4R neural circuits affecting sympathetic tone in mice. To this end, we injected Cre-dependent AAV driving eYFP-fused channel rhodopsin-2 expression into the PVN of MC4R-t2a-Cre knock-in mice, which allow targeted anterograde tract-tracing of PVN MC4R neurons throughout the brain. In addition to known brain region for feeding behavior (i.e. parabrachial nucleus), we found broad innervations of PVN MC4R neurons to various brain regions important for autonomic-cardiovascular control, including, but not limited to, nucleus of solitary tractus, dorsomotor nucleus of vagus, and ventrolateral medulla. Considerable innervation was also evident in spinal cord, which is further confirmed by Fluoro-gold (FG)-mediated retrograde tracing in the spinal cord (thoracic T6-10) of MC4R-GFP transgenic mouse. Double immunofluorescence labeling of GFP and FG revealed that ~50% (58 out of 116) MC4R neurons in the posterior parvocellular subdivision of PVN project to thoracic spinal cord. Furthermore, microinjection of synthetic MC4R agonist (MTII) into the PVN evokes ~42% increase (from baseline) in renal sympathetic nerve activity in anesthetized mice. These results provide important insights into understanding the divergent neural circuits by which PVN MC4R signaling differentially regulates metabolic and cardiovascular functions. Functional dissection of these diverging neural pathways using optogenetic/chemogenetic approaches is ongoing.

1 September 2018 in Hypertension
Verified
Journal Article
Closed access
JWJing Wu
Jing Wu
LALarry N Agbor
Larry N Agbor
MMMasashi Mukohda
Masashi Mukohda
ANAnand R Nair
Anand R Nair
PNPablo Nakagawa
Pablo Nakagawa
CSCurt D Sigmund
Curt D Sigmund
Mutations in PPARγ cause hypertension (HT) while PPARγ activation lowers blood pressure (BP) in humans. To determine if vascular smooth muscle (VSM) PPARγ regulates salt sensitivity, we studied transgenic mice selectively expressing a HT-causing PPARγ mutant in VSM (S-P467L) and non-transgenic littermates (NT) fed a 4% high salt (HS) diet for 4 weeks. Salt equally suppressed plasma renin in both strains, but S-P467L mice exhibited increased systolic BP (S-P467L 136±3 mmHg vs NT 124±2 mmHg, p<0.01) and pulse wave velocity (3.1±0.1 vs 2.7±0.1 m/s, p<0.01) in response to HS. The salt-induced HT was not associated with changes in diastolic BP, sympathetic nerve activity, heart rate, or cardiac output. Thus, the pressor effect of HS was likely due to higher peripheral vascular resistance. HS-fed S-P467L mice developed impaired acetylcholine (ACh)- and sodium nitroprusside (SNP)-induced vasorelaxation in carotid (Max ACh relaxation: 31±4.9% vs 90±1.8%, p<0.01; Max SNP relaxation: 38±2.8% vs 89±2.6%, p<0.01) and basilar artery (Max ACh relaxation: -3.2±9.3% vs 57±5.9%, p<0.01). The impaired vasodilation rapidly developed after 3-day HS diet, preceding salt-induced BP elevation. Pre-incubation with a cyclooxygenase inhibitor indomethacin normalized ACh/SNP relaxation responses, and preliminary mass spectrometry indicated HS increased prostaglandin E2 in S-P467L aortas. HS-fed S-P467L mice had smaller renal artery luminal diameter (322±21 vs 389±22 μm, p<0.05) and blunted renal blood flow (36±3.6 vs. 50±6.4 μL/min/g, p<0.05). During the 4 th week of HS diet, S-P467L mice produced 31% less nitrate/nitrite in 24 hour urine compared to NT controls (2.2±0.3 vs 3.2±0.4 μmol, p<0.05), suggesting blunted renal bioavailability of nitric oxide, a potent inhibitor of Na-K-2Cl cotransporter (NKCC2). This was associated with a declined capacity of HS-fed S-P467L mice to excrete an acute volume/Na + load, which was rescued by an NKCC2 inhibitor furosemide, but not by the Na-Cl-cotransporter inhibitor hydrochlorothiazide. Our data support the novel concept that smooth muscle PPARγ regulates systemic vascular resistance, renal perfusion and tubular sodium transport, and loss of these protective actions of PPARγ predisposes to salt sensitivity and hypertension.